Received: 19 April 2021
Accepted: 16 September 2021
First Online: 2 October 2021
: The study was approved by the IRB of the Instituto de Alta Complejidad Oftalmos, Buenos Aires, Argentina.
: Not applicable.
: CID, MVC, VCR and FDR declare that they have competing interests.AA has participated in advisory boards for Roche, Alcon, Bayer and Novartis.MZ has received speaker fees from Alcon, Bayer, Abbvie, Poen and Novo Nordisk.LW has received speaker fees from Bayer and Quantel Medical